ArticleOncotarget2018
Oridonin inhibits aberrant AKT activation in breast cancer.
Bowen Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleOncotarget2018
Bowen Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.